Literature DB >> 10478571

Beta-adrenoceptor reserve in human lung: a comparison between airway smooth muscle and mast cells.

L K Chong1, P T Peachell.   

Abstract

The effects of several beta-adrenoceptor agonists on the relaxation of precontracted human bronchial rings and the inhibition of IgE-mediated histamine release from human lung mast cells (HLMC) were studied. For the relaxation of bronchial rings, isoprenaline, fenoterol and terbutaline were full agonists whereas salbutamol was a full agonist in some (two out of six) experiments and a partial agonist in the remainder. For the inhibition of histamine release, relative to isoprenaline, neither fenoterol, terbutaline nor salbutamol was a full agonist. Studies with the irreversible beta-adrenoceptor antagonist, bromoacetylalprenolol menthane, indicated that there was a larger beta-adrenoceptor reserve for the relaxation of precontracted bronchial rings than for the inhibition of histamine release from HLMC. Further studies indicated that the isoprenaline inhibition of histamine release was considerably more susceptible to desensitizing treatments than the isoprenaline relaxation of bronchial rings. Collectively, these data suggest that a larger beta-adrenoceptor reserve exists for the relaxation of smooth muscle than the inhibition of histamine release from HLMC and that differences in receptor reserve may contribute to the relative susceptibilities of the two systems to desensitization.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10478571     DOI: 10.1016/s0014-2999(99)00425-2

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  10 in total

Review 1.  Regulation of mast cells by beta-agonists.

Authors:  Peter Peachell
Journal:  Clin Rev Allergy Immunol       Date:  2006 Oct-Dec       Impact factor: 8.667

Review 2.  Pharmacotherapy of asthma.

Authors:  Martin M Zdanowicz
Journal:  Am J Pharm Educ       Date:  2007-10-15       Impact factor: 2.047

Review 3.  Agonist efficacy and receptor desensitization: from partial truths to a fuller picture.

Authors:  Steven J Charlton
Journal:  Br J Pharmacol       Date:  2009-09       Impact factor: 8.739

4.  Adrenoceptor activity of muscarinic toxins identified from mamba venoms.

Authors:  K Näreoja; J P Kukkonen; S Rondinelli; D M Toivola; J Meriluoto; J Näsman
Journal:  Br J Pharmacol       Date:  2011-09       Impact factor: 8.739

5.  Desensitisation of mast cell beta2-adrenoceptor-mediated responses by salmeterol and formoterol.

Authors:  Anne-Marie Scola; Lee K Chong; S Kim Suvarna; Russell Chess-Williams; Peter T Peachell
Journal:  Br J Pharmacol       Date:  2003-12-08       Impact factor: 8.739

6.  Influence of agonist intrinsic activity on the desensitisation of beta2-adrenoceptor-mediated responses in mast cells.

Authors:  Anne-Marie Scola; Lee K Chong; Russell Chess-Williams; Peter T Peachell
Journal:  Br J Pharmacol       Date:  2004-08-02       Impact factor: 8.739

7.  The long-acting beta-adrenoceptor agonist, indacaterol, inhibits IgE-dependent responses of human lung mast cells.

Authors:  Anne-Marie Scola; Matthew Loxham; Steven J Charlton; Peter T Peachell
Journal:  Br J Pharmacol       Date:  2009-04-09       Impact factor: 8.739

8.  Desensitization of beta2-adrenoceptor-mediated responses by short-acting beta2-adrenoceptor agonists in human lung mast cells.

Authors:  Lee K Chong; Kim Suvarna; Russell Chess-Williams; Peter T Peachell
Journal:  Br J Pharmacol       Date:  2003-02       Impact factor: 8.739

9.  An estimation of beta 2-adrenoceptor reserve on human bronchial smooth muscle for some sympathomimetic bronchodilators.

Authors:  Mark A Giembycz
Journal:  Br J Pharmacol       Date:  2009-05-14       Impact factor: 8.739

10.  Functional desensitization of the β 2 adrenoceptor is not dependent on agonist efficacy.

Authors:  Elizabeth M Rosethorne; Michelle E Bradley; Toby C Kent; Steven J Charlton
Journal:  Pharmacol Res Perspect       Date:  2015-01-05
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.